Jacques Carolan
@jacquescarolan.bsky.social
140 followers 120 following 29 posts
Applied Physicist & Neuroscientist || Current: Programme Director @ ARIA || Previous: Neuroscience @ UCL & Quantum Computing @ MIT || He/Him https://www.aria.org.uk https://jacquescarolan.github.io
Posts Media Videos Starter Packs
Pinned
jacquescarolan.bsky.social
🚨I’m super excited to announce the teams we’re funding as part of our Precision Neurotechnologies programme.🚨
They’ll work on the next-gen tech that’ll allow us to understand + treat a wider range of brain disorders than ever before. Read more below (1/3) @aria-research.bsky.social
aria-research.bsky.social
We’re excited to announce the 18 teams we’re funding in Precision Neurotechnologies 🧠 They’ll work to unlock new ways to interface with the brain at the neural circuit level, with unprecedented precision. (1/3)
jacquescarolan.bsky.social
Finally: on a personal note this has been such a wild journey. I spent 10 years building quantum computers and then jacked it all in to try and become a neuroscientist (I don't have high-school biology lol). The reason I could do this is because of wonderful friends at the Neural Computation Lab!
jacquescarolan.bsky.social
Finally, we used this to probe synaptic plasticity. Pairing climbing fibre input before granule cell activation induced potentiation of IPSPs, lasting at least 40 min. Smaller IPSPs potentiated more, and neighbours co-potentiated — revealing circuit-level learning rules.
jacquescarolan.bsky.social
Because we could image full dendritic arbors across multiple cells, we saw rich circuit dynamics: precise synchrony of CF-evoked events, spatially diverse inhibition across branches, and global vs local patterns of dendritic activity.
jacquescarolan.bsky.social
With this, we captured high-fidelity recordings of spontaneous and sensory-evoked complex spikes, optogenetically evoked IPSPs (via feedforward inhibition) + even the occasional EPSP!
jacquescarolan.bsky.social
We expressed JEDI-2Psub in Purkinje cell dendrites and opsins in cerebellar granule cells. This enables us to both image voltage at postsynaptic dendrites and precisely activate presynaptic inputs with light.
jacquescarolan.bsky.social
At the heart of this is a new voltage indicator — JEDI-2Psub — from colleagues at the St.Pierre Lab. Optimised for subthreshold signals, it gives ~3.5× larger responses near rest compared to JEDI-2P. This makes it ideal for capturing synaptic potentials.
jacquescarolan.bsky.social
SUPER excited that my first ever *real* neuroscience paper is published today in Nat Comms!🥳

We combined two-photon voltage imaging ⚡️and optogenetics 🔦to probe synaptic plasticity in the cerebellum of awake behaving mice. 🧵
jacquescarolan.bsky.social
That’s the vision we’re exploring.

If you’re working on transformative, unconventional ideas to 1000x the scale of neurotech or have answers to the following questions — I’d love to hear from you!

📖 Full post: link.aria.org.uk/jacquessubst...
jacquescarolan.bsky.social
Neurotech needs the same inflection point.

From invasive, last-resort procedures → simple, scalable, globally accessible platforms.

The 1950s had the transistor. Today the convergence of engineered biology + hardware could make a surgery-free, platform neurotechnology possible
jacquescarolan.bsky.social
I think cardiology in the 1950s is a great case study, where treating heart block required open-heart surgery.

The leap wasn’t “better surgery.”
It was the transvenous lead — a minimally invasive access route that unlocked millions of pacemaker implants/year. ❤️⚡
jacquescarolan.bsky.social
DBS for PD is a great proof point: effective, approved, reimbursed… yet only a fraction of people eligible receive it.

Complex surgery imposes a series of stacked, multiplicative barriers that fundamentally limit scalability.

So what do we do?
jacquescarolan.bsky.social
Emerging therapies show real promise:

⚡ Targeted electrical stimulation for intractable psychiatric disorders
🧬 Cell therapies for neurodegenerative disease

But they won’t scale to the millions who need them.
doi.org/10.1016/j.br...
doi.org/10.1016/j.pa...
https://doi.org/10.1016/j.brs.2025.08.017
t.co
jacquescarolan.bsky.social
We’re facing a global brain-health crisis:

🧠 Brain disorders = biggest disease burden worldwide
💔 3× that of heart disease
💰 Costs US + Europe $1.7 trillion annually

And the gap between need & treatment is only widening.
doi.org/10.1159/0005...
jacquescarolan.bsky.social
I’ve been thinking a lot about how we scale neurotech.

Current approaches (e.g. DBS for PD) aren’t meeting the need. Emerging ones may fare even worse.

That’s why I’m scoping a new @aria-research.bsky.social programme to develop neurotech built for scale.

Check out my post +share feedback!👇
Reposted by Jacques Carolan
aria-research.bsky.social
What if we could engineer the innate immune system for broad, long-lasting resilience?

Our latest thesis, Sustained Viral Resistance, proposes using AI, synthetic biology + materials chemistry to catalyse a new era of innate immunotherapies.

Dive in/give feedback: link.aria.org.uk/sii-progthes...
Sculpting Innate Immunity
The immune system sustains human health via the complementary action of its two branches: the innate and the adaptive immune systems. Precision modulation of innate immunity can unlock transformative ...
link.aria.org.uk
jacquescarolan.bsky.social
wait... fungi display action potentials?!🤯

"Two types of spiking activity are uncovered: high-frequency (period 2.6 min) and low-frequency (period 14 min) .."

is this well known in biology? like, if I actually studied it at school would I know this? so cool!
jacquescarolan.bsky.social
Love this. Definitely the cerebellum. Specifically how different cell types map onto specific components of an adaptive filter www.nature.com/articles/nrn...
Reposted by Jacques Carolan
motifneuro.bsky.social
We've been selected by @aria-research.bsky.social to develop a network of neural devices designed to monitor and regulate mental and cognitive states without brain surgery. The UK-based program led by @jacquescarolan.bsky.social is contributing £69M to unlock the full potential of #neurotech.
aria-research.bsky.social
We’re excited to announce the 18 teams we’re funding in Precision Neurotechnologies 🧠 They’ll work to unlock new ways to interface with the brain at the neural circuit level, with unprecedented precision. (1/3)
Reposted by Jacques Carolan
ahmarilab.bsky.social
🚨 hey hey everyone interested in non-invasive precision #neurotech for neuropsych disease: ARIA's Precision Neurotechnologies Program teams announced!

Kudos to PD @jacquescarolan.bsky.social for putting together an amazing group👏👏👏 Excitedly watching this space 👀🍿

www.aria.org.uk/opportunity-...
Precision Neurotechnologies
Backed by £69m, this programme aims to unlock new methods to interface with the human brain at the cellular level, with unprecedented precision.
www.aria.org.uk
jacquescarolan.bsky.social
Thanks for amplifying Susanne! Inspired by your awesome work over at Wellcome Leap.
jacquescarolan.bsky.social
A 'programme' should bring teams together to create some kind of nonlinear reaction which just isn't possible by funding them in isolation. I can't wait to see the synergies and interactions that come out of this incredible group 🧪(3/3)
jacquescarolan.bsky.social
Some of the things I'm most excited by are (a) the diversity of technologies we can support (biohybrids🧫, gene therapies🧬 microscopic CMOS robots🤖 acoustic🔊 and electrical interfaces⚡️) and (b) the variety of institutions (academia, startups, hospitals, non-profits) (2/3)